Completed
CTN 214: Effect of a one-year course of HAART in acute/early HIV
A randomized trial of highly active antiretroviral therapy in acute/early HIV infection
Learn MoreCompleted
A randomized trial of highly active antiretroviral therapy in acute/early HIV infection
Learn MoreCompleted
Use of valproic acid to purge HIV from resting CD4+ memory cells: Trial results
Learn MoreCompleted
A Phase I/II safety and immunogencity study of a combination of whole-killed HIV-1 antigen and Amplivax, administered with or without IFA, in HIV-1 infected Participants: Trial results
Learn MoreCompleted
Trial of Citalopram for the Prevention of Depression
Learn MoreCompleted
A Comparison of Two Ways to Manage Anti-HIV Treatment
Learn MoreCompleted
A pilot study to determine the impact of therapeutic HIV vaccination followed by a scheduled interruption of antiretroviral therapy on HIV-specific immune function and virologic rebound in patients with prolonged viral suppression: Trial results
Learn MoreCompleted
A tri-national (Canada, UK, USA) randomized, controlled trial to determine the optimal management of patients with HIV infection for whom first and second-line highly active antiretroviral therapy has failed
Learn MoreCompleted
A Prospective Randomized Trial of Structured Treatment Interruption (STI) Followed by the Initiation of a New Antiretroviral Regimen vs. Immediate Switching to a New Antiretroviral Regimen in HIV-Infected Patients Experiencing Virologic Failure on HAART
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.